PHAT — Phathom Pharmaceuticals, Inc. stock price, charts and financials

QT30Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.45
-0.53-5.90%
OverviewShort InterestFilings
PHATQT30Phathom Pharmaceuticals, Inc.·NASDAQ
8.45-5.90%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 202610-QQuarterly report
Jul 30, 20268-KCurrent report
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 20, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 16, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 21, 20268-KCurrent report
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
Apr 30, 202610-QQuarterly report
Apr 30, 20268-KCurrent report
Apr 07, 2026ARSAnnual report to shareholders
Apr 07, 2026DEFA14AAdditional proxy soliciting materials
Apr 07, 2026DEF 14ADefinitive proxy statement
Mar 27, 2026S-8Registration of employee benefit securities
Mar 12, 2026SC 13GBeneficial ownership statement (passive)
Mar 11, 20264Statement of changes in beneficial ownership
Mar 03, 20264Statement of changes in beneficial ownership
Feb 26, 20268-KCurrent report
#1 / 25 of 339
Page
▼
/ 14